$CAPS Income Statement | Understand Stock

$CAPS

$2.62 +$0.01 (0.38%) Live

$CAPS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Operations

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016
Sales
Sales returns and allowances
Sublicense Transaction Costs
General and administrative
Research and development
Total operating expenses
Net sales
Cost of goods sold
Gross Profit
Selling, general and administrative expenses
Impairment of goodwill
Transaction expenses
Income (loss) from operations
Loss on asset disposal
Change in fair value of derivative liability
Interest expense
Other income (expense), net
Income from continuing operations before taxes
Provision for Income Taxes (expense)
Less: Net Income (Loss) attributable to the noncontrolling interest
Net Income (Loss)
Net Income (Loss), basic and diluted, attributable to Capstone Therapeutic Corp. stockholders
Basic and diluted shares outstanding
Class B units preferred return
Dividends, Adjustment
Special Preferred Units
Class B Preferred Units
Net Income (loss) attributable to Capstone Holding Corp. stockholders
Other Comprehensive Loss
Foreign currency translation adjustment
Comprehensive Loss
Earnings (loss) per share:
Net loss per share attributable to Capstone Holding Corp. stockholders – basic and diluted (in dollars per share)
Net loss per share attributable to Capstone Holding Corp. stockholders – Diluted (in Dollars per share)
Weighted average number of common shares outstanding – basic and diluted (in shares)
Weighted average number of common shares outstanding – Diluted (in Shares)

Comments